🇺🇸 FDA
Pipeline program

Rademikibart in prefilled syringe

CBP-201-207

Phase 2 other active

Quick answer

Rademikibart in prefilled syringe for COPD Acute Exacerbation is a Phase 2 program (other) at S.L with 1 ClinicalTrials.gov record(s).

Program details

Company
S.L
Indication
COPD Acute Exacerbation
Phase
Phase 2
Modality
other
Status
active

Clinical trials